For children born with inoperable congenital heart disease oradvanced cardiomyopathy, cardiac transplantation is the onlytherapeutic option. Each year in the United States, approximately400 heart-transplantation procedures are performed in childrenand adolescents. In about two thirds, the indication is complexcongenital heart disease, and in the remainder it is cardiomyopathy.During the past decade, the procedure has proved lifesavingfor thousands of children.
Of the 400 pediatric heart transplantations performed annually,about 100 are in infants under the age of 1 year. The 15-yearsurvival rate among these infants is greater than 50%, increasingto 80% among those . . . [Full Text of this Article]
This article has been cited by other articles:
Chrispin, E, Conlon Vaswani, N, English, V, Harrison, C, Sheather, J, Sommerville, A
(2008). Ethics briefings. J. Med. Ethics
34: 829-830
[Full Text]
Previous
Perspective Roundtable
